Literature DB >> 24751667

Incorporation of ortho- and meta-tyrosine into cellular proteins leads to erythropoietin-resistance in an erythroid cell line.

Esztella Mikolás1, Szilárd Kun, Boglárka Laczy, Gergő A Molnár, Eszter Sélley, Tamás Kőszegi, István Wittmann.   

Abstract

BACKGROUND/AIMS: Erythropoietin-resistance is an unsolved concern in the treatment of renal anaemia. We aimed to investigate the possible role of ortho- and meta-tyrosine - the hydroxyl free radical products of L-phenylalanine - in the development of erythropoietin-resistance.
METHODS: TF-1 erythroblast cell line was used. Cell concentration was determined on day 1; 2 and 3 by two independent observers simultaneously in Bürker cell counting chambers. Protein concentration was determined with colorimetric method. Para-, ortho- and meta-tyrosine levels were measured using reverse phase-HPLC with fluorescence detection. Using Western blot method activating phosphorylation of STAT5 and ERK1/2 were investigated.
RESULTS: We found a time- and concentration-dependent decrease of erythropoietin-induced proliferative activity in case of ortho- and meta-tyrosine treated TF-1 erythroblasts, compared to the para-tyrosine cultured cells. Decreased erythropoietin-response could be regained with a competitive dose of para-tyrosine. Proteins of erythroblasts treated by ortho- or meta-tyrosine had lower para-tyrosine and higher ortho- or meta-tyrosine content. Activating phosphorylation of ERK and STAT5 due to erythropoietin was practically prevented by ortho- or meta-tyrosine treatment.
CONCLUSION: According to this study elevated ortho- and meta-tyrosine content of erythroblasts may lead to the dysfunction of intracellular signaling, resulting in erythropoietin-hyporesponsiveness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24751667     DOI: 10.1159/000355770

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  7 in total

Review 1.  Tyrosine isomers and hormonal signaling: A possible role for the hydroxyl free radical in insulin resistance.

Authors:  Gergő A Molnár; Esztella Zsóka Mikolás; István András Szijártó; Szilárd Kun; Eszter Sélley; István Wittmann
Journal:  World J Diabetes       Date:  2015-04-15

2.  Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing meta-tyrosine in Caenorhabditis elegans.

Authors:  Brett R Ipson; Rebecca A Green; John T Wilson; Jacob N Watson; Kym F Faull; Alfred L Fisher
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

3.  Incorporation of Oxidized Phenylalanine Derivatives into Insulin Signaling Relevant Proteins May Link Oxidative Stress to Signaling Conditions Underlying Chronic Insulin Resistance.

Authors:  Judit Mohás-Cseh; Gergő Attila Molnár; Marianna Pap; Boglárka Laczy; Tibor Vas; Melinda Kertész; Krisztina Németh; Csaba Hetényi; Orsolya Csikós; Gábor K Tóth; Attila Reményi; István Wittmann
Journal:  Biomedicines       Date:  2022-04-22

Review 4.  Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review.

Authors:  Gergő A Molnár; Szilárd Kun; Eszter Sélley; Melinda Kertész; Lívia Szélig; Csaba Csontos; Katalin Böddi; Lajos Bogár; Attila Miseta; István Wittmann
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 5.  Toxicity of meta-Tyrosine.

Authors:  Marcin Tyminski; Katarzyna Ciacka; Pawel Staszek; Agnieszka Gniazdowska; Urszula Krasuska
Journal:  Plants (Basel)       Date:  2021-12-17

6.  Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine.

Authors:  Szilárd Kun; Gergő A Molnár; Eszter Sélley; Lívia Szélig; Lajos Bogár; Csaba Csontos; Attila Miseta; István Wittmann
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

Review 7.  Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress.

Authors:  Brett R Ipson; Alfred L Fisher
Journal:  Ageing Res Rev       Date:  2016-03-31       Impact factor: 10.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.